Skip to Main Content

Paper Details

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
JAMA Netw Open
16
2021
BCR, Cancer, Cancer of the Prostate, DM, PCSM, PSA, PSMA, Prostate, Prostate-Specific Membrane Antigen, Prostate-specific membrane antigen, androgen, patients, prostate cancer, prostate-specific antigen, risk
Adult, Aged, Aged, 80 and over, Antigens, Surface, Biomarkers, Tumor, Clinical Decision Rules, Follow-Up Studies, Glutamate Carboxypeptidase II, Humans, Male, Middle Aged, Neoplasm Staging, Nomograms, Positron Emission Tomography Computed Tomography, Prognosis, Prostatic Neoplasms, Retrospective Studies, Risk Assessment, SEER Program, Survival Analysis
Author NameAffiliation
Michael XiangUniversity of California los angeles
Ting Martin MaUniversity of California los angeles
Ricky SavjaniUniversity of California los angeles
Erqi L PollomStanford University
Robert Jeffrey KarnesMayo Clinic
Tristan GroganDavid Geffen School of Medicine at university of california los angeles
Tristan GroganDavid Geffen School of Medicine at university of california los angeles
Jessica K WongFox Chase Cancer Center
Giovanni MotterleMayo Clinic
Jeffrey J TosoianUniversity of Michigan ann arbor
Bruce J TrockBrady Urological Institute, Johns Hopkins University
Eric A KleinGlickman Urological and Kidney Institute, Cleveland Clinic
Bradley J StishMayo Clinic
Robert T DessUniversity of Michigan ann arbor
Daniel E SprattUniversity of Michigan ann arbor
Avinash PilarUniversity of Toronto
Chandana A ReddyTaussig Cancer Institute, Cleveland Clinic
Rebecca Levin-EpsteinUniversity of California los angeles
Trude B WeddeOslo University Hospital, Norwegian Radium Hospital
Wolfgang LillebyOslo University Hospital, Norwegian Radium Hospital
Ryan FianoSchiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University
Gregory S MerrickSchiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University
Richard G StockIcahn School of Medicine at Mount Sinai
David Jeffrey DemanesUniversity of California los angeles
Brian J MoranProstate Cancer Foundation of Chicago
Hartwig HulandMartini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf
Phuoc T TranJohns Hopkins University School of Medicine
Santiago MartinClinica Universitaria de Navarra, University of Navarra
Rafael Mart??nez-MongeClinica Universitaria de Navarra, University of Navarra
Daniel J KraussOakland University William Beaumont School of Medicine
Eyad Abu-IsaUniversity of Michigan ann arbor
Ridwan AlamBrady Urological Institute, Johns Hopkins University
Zeyad R SchwenBrady Urological Institute, Johns Hopkins University
Thomas M PisanskyMayo Clinic
C Richard ChooMayo Clinic
Danny Y SongJohns Hopkins University School of Medicine
Stephen GrecoJohns Hopkins University School of Medicine
Curtiland DevilleJohns Hopkins University School of Medicine
Todd McNuttJohns Hopkins University School of Medicine
Theodore L DeWeeseJohns Hopkins University School of Medicine
Ashley E RossNorthwestern University Feinberg School of Medicine
Jay P CiezkiTaussig Cancer Institute, Cleveland Clinic
Paul C BoutrosUniversity of California los angeles
Nicholas G NickolsUniversity of California los angeles
Nicholas G NickolsVeterans Affairs (VA) Greater Los Angeles Healthcare System
Prashant BhatUniversity of California los angeles
David ShabsovichUniversity of California los angeles
Jesus E JuarezUniversity of California los angeles
Natalie ChongUniversity of California los angeles
Patrick A KupelianUniversity of California los angeles
  • 1 - 50

Datasets